A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

In a recent transaction, Grigorios Siokas, the Chief Executive Officer of Cosmos Health Inc. (NASDAQ:COSM), acquired 51,414 shares of the company's common stock. The shares were purchased at a price ...

Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

Strictly Come Dancing's Amy Dowden has bravely spoken about the severe health challenges she faces due to Crohn's disease. On ...

Rheumatoid Arthritis Awareness Day 2025 falls on February 2 to raise awareness around the chronic autoimmune disease.

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal ...

Other research has shown red light therapy could minimize the appearance of wrinkles, hyperpigmentation, and broken blood ...

A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Celltrion, a major South Korean biopharmaceutical firm, on Friday said its new biosimilar for an autoimmune disease treatment has received approval from the US Food and Drug Administration (FDA). The ...